Article
T Helper Cell Lineage-Defining Transcription Factors: Potent Targets for Specific GVHD Therapy?
5 Jan 2022
Abstract excerpt
Allogenic hematopoietic stem cell transplantation (allo-HSCT) represents a potent and potentially curative treatment for many hematopoietic malignancies and hematologic disorders in adults and children. The donor-derived immunity, elicited by the stem cell transplant, can prevent disease relapse but is also responsible for the induction of graft-versus-host disease (GVHD). The pathophysiology of acute GVHD is not...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
